Search

Author/Creator Dreiling, Lyndah

1. Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial. Issue 3 (March 2017)

Authors:
Jones, Jeffrey A; Robak, Tadeusz; Brown, Jennifer R; Awan, Farrukh T; Badoux, Xavier; Coutre, Steven; Loscertales, Javier; Taylor, Kerry; Vandenberghe, Elisabeth; Wach, Malgorzata; Wagner-Johnston, Nina; Ysebaert, Loic; Dreiling, Lyndah; Dubowy, Ronald; Xing, Guan; Flinn, Ian W; Owen, Carolyn
Journal:
Lancet
Issue:
Volume 4:Issue 3(2017)
Page Start:
e114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. Issue 6 (12th May 2019)

Authors:
Soumerai, Jacob D.; Ni, Ai; Xing, Guan; Huang, Julie; Furman, Richard R.; Jones, Jeffrey; Sharman, Jeffrey P.; Hallek, Michael; Adewoye, Adeboye H.; Dubowy, Ronald; Dreiling, Lyndah; Zelenetz, Andrew D.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 6(2019)
Page Start:
1438
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia. Issue 3 (June 2018)

Authors:
Coutre, Steven E.; Flinn, Ian W.; de Vos, Sven; Barrientos, Jacqueline C.; Schreeder, Marshall T.; Wagner-Johnson, Nina D.; Sharman, Jeff P.; Boyd, Thomas E.; Fowler, Nathan; Dreiling, Lyndah; Kim, Yeonhee; Mitra, Siddhartha; Rai, Kanti; Leonard, John P.; Furman, Richard R.
Journal:
HemaSphere
Issue:
Volume 2:Issue 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search